AIMS: The macrophage migration inhibitory factor (MIF) is an intracellular inhibitor of the central nervous system actions of angiotensin II on blood pressure. Considering that angiotensin II actions at the nucleus of the solitary tract are important for the maintenance of hypertension in spontaneously hypertensive rats (SHRs), we tested if increased MIF expression in the nucleus of the solitary tract of SHR alters the baseline high blood pressure in these rats. METHODS AND RESULTS: Eight-week-old SHRs or normotensive rats were microinjected with the vector AAV2-CBA-MIF into the nucleus of the solitary tract, resulting in MIF expression predominantly in neurons. Rats also underwent recordings of the mean arterial blood pressure (MAP) and heart rate (via telemetry devices implanted in the abdominal aorta), cardiac- and baroreflex function. Injections of AAV2-CBA-MIF into the nucleus of the solitary tract of SHRs produced significant decreases in the MAP, ranging from 10 to 20 mmHg, compared with age-matched SHRs that had received identical microinjections of the control vector AAV2-CBA-eGFP. This lowered MAP in SHRs was maintained through the end of the experiment at 31 days, and was associated with an improvement in baroreflex function to values observed in normotensive rats. In contrast to SHRs, similar increased MIF expression in the nucleus of the solitary tract of normotensive rats produced no changes in baseline MAP and baroreflex function. CONCLUSION: These results indicate that an increased expression of MIF within the nucleus of the solitary tract neurons of SHRs lowers blood pressure and restores baroreflex function.
AIMS: The macrophage migration inhibitory factor (MIF) is an intracellular inhibitor of the central nervous system actions of angiotensin II on blood pressure. Considering that angiotensin II actions at the nucleus of the solitary tract are important for the maintenance of hypertension in spontaneously hypertensiverats (SHRs), we tested if increased MIF expression in the nucleus of the solitary tract of SHR alters the baseline high blood pressure in these rats. METHODS AND RESULTS: Eight-week-old SHRs or normotensive rats were microinjected with the vector AAV2-CBA-MIF into the nucleus of the solitary tract, resulting in MIF expression predominantly in neurons. Rats also underwent recordings of the mean arterial blood pressure (MAP) and heart rate (via telemetry devices implanted in the abdominal aorta), cardiac- and baroreflex function. Injections of AAV2-CBA-MIF into the nucleus of the solitary tract of SHRs produced significant decreases in the MAP, ranging from 10 to 20 mmHg, compared with age-matched SHRs that had received identical microinjections of the control vector AAV2-CBA-eGFP. This lowered MAP in SHRs was maintained through the end of the experiment at 31 days, and was associated with an improvement in baroreflex function to values observed in normotensive rats. In contrast to SHRs, similar increased MIF expression in the nucleus of the solitary tract of normotensive rats produced no changes in baseline MAP and baroreflex function. CONCLUSION: These results indicate that an increased expression of MIF within the nucleus of the solitary tract neurons of SHRs lowers blood pressure and restores baroreflex function.
Authors: Melissa A Burmeister; Colin N Young; Valdir A Braga; Scott D Butler; Ram V Sharma; Robin L Davisson Journal: Hypertension Date: 2010-12-20 Impact factor: 10.190
Authors: Elizabeth B Oliveira-Sales; Erika E Nishi; Bruno A Carillo; Mirian A Boim; Miriam S Dolnikoff; Cássia T Bergamaschi; Ruy R Campos Journal: Am J Hypertens Date: 2009-02-19 Impact factor: 2.689
Authors: Thiago S Moreira; Ana C Takakura; Eduardo Colombari; José V Menani Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-04-01 Impact factor: 3.619
Authors: Eduardo Colombari; Debora S A Colombari; Hongwei Li; Peng Shi; Ying Dong; Nan Jiang; Mohan K Raizada; Colin Sumners; David Murphy; Julian F R Paton Journal: Hypertension Date: 2010-10-11 Impact factor: 10.190
Authors: Rafaela Moreira Barbosa; Guilherme F Speretta; Daniel Penteado Martins Dias; Prashant Jay Ruchaya; Hongwei Li; José Vanderlei Menani; Colin Sumners; Eduardo Colombari; Débora S A Colombari Journal: Am J Hypertens Date: 2017-04-01 Impact factor: 2.689
Authors: Benedek Erdos; Rebekah R Clifton; Meng Liu; Hongwei Li; Michael L McCowan; Colin Sumners; Deborah A Scheuer Journal: Am J Physiol Heart Circ Physiol Date: 2015-06-12 Impact factor: 4.733
Authors: Mariana R Lauar; Graziela T Blanch; Débora S A Colombari; Eduardo Colombari; Patrícia M De Paula; Laurival A De Luca; José V Menani Journal: Hypertens Res Date: 2020-05-27 Impact factor: 3.872
Authors: Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners Journal: Pharmacol Ther Date: 2013-02-28 Impact factor: 12.310
Authors: Guilherme F Speretta; Prashant J Ruchaya; Maria A Delbin; Mariana R Melo; Hongwei Li; José V Menani; Colin Sumners; Eduardo Colombari; Mirian Bassi; Débora S A Colombari Journal: Hypertens Res Date: 2019-01-10 Impact factor: 3.872
Authors: Yanling Zhang; Yongxin Gao; Robert C Speth; Nan Jiang; Yingying Mao; Colin Sumners; Hongwei Li Journal: Int J Med Sci Date: 2013-03-20 Impact factor: 3.738